These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1278751)

  • 1. Proceedings: Lithocholate kinetics in patients ingesting chenodeoxycholic (chenic) acid for gall stone dissolution.
    Allan R; Hofmann AF
    Gut; 1976 May; 17(5):394. PubMed ID: 1278751
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of primary bile acid ingestion on bile acid metabolism and biliary lipid secretion in gallstone patients.
    LaRusso NF; Hoffman NE; Hofmann AF; Northfield TC; Thistle JL
    Gastroenterology; 1975 Dec; 69(6):1301-14. PubMed ID: 1193329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithocholate metabolism during chemotherapy for gallstone dissolution. 2. Absorption and sulphation.
    Allan RN; Thistle JL; Hofmann AF
    Gut; 1976 Jun; 17(6):413-9. PubMed ID: 955496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased sulfation of lithocholate in patients with cholesterol gallstones during chenodeoxycholate treatment.
    Stiehl A; Raedsch R; Kommerell B
    Digestion; 1975; 12(2):105-10. PubMed ID: 1158064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
    Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
    J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Increasing sulfatization of lithocholic acid during chenodeoxycholic acid treatment].
    Raedsch R; Stiehl A
    Verh Dtsch Ges Inn Med; 1974; 80():447-8. PubMed ID: 4454582
    [No Abstract]   [Full Text] [Related]  

  • 7. Lithocholate metabolism during chenotherapy for gallstone dissolution. 1. Serum levels of sulphated and unsulphated lithocholates.
    Allan RN; Thistle JL; Hofmann AF; Carter JA; Yu PY
    Gut; 1976 Jun; 17(6):405-12. PubMed ID: 955495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medical treatment of cholelithiasis by chenodeoxycholic acid. Chenodeoxycholic acid biotransformation and significance of lithocholic acid sulphate (author's transl)].
    Hrabák P; Dosková M; Soucková E; Konecný K; Holásková M
    Cas Lek Cesk; 1979 Aug; 118(35):1078-82. PubMed ID: 519676
    [No Abstract]   [Full Text] [Related]  

  • 9. Bile salts in health and disease.
    Papp JP
    Mich Med; 1972 Oct; 71(30):865-9. PubMed ID: 4567570
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of gallbladder in gallstone formation.
    Nakayama F; van der Linden W
    Acta Chir Scand; 1974; 140(1):45-9. PubMed ID: 4819022
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism of lithocholate in healthy man. II. Enterohepatic circulation.
    Cowen AE; Korman MG; Hofmann AF; Cass OW; Coffin SB
    Gastroenterology; 1975 Jul; 69(1):67-76. PubMed ID: 1097294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative formation of lithocholic acid from chenodeoxycholic and ursodeoxycholic acids in the colon.
    Bazzoli F; Fromm H; Sarva RP; Sembrat RF; Ceryak S
    Gastroenterology; 1982 Oct; 83(4):753-60. PubMed ID: 7106506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lack of relationship between hepatotoxicity and lithocholic-acid sulfation in biliary bile acids during chenodiol therapy in the National Cooperative Gallstone Study.
    Fisher RL; Hofmann AF; Converse JL; Rossi SS; Lan SP
    Hepatology; 1991 Sep; 14(3):454-63. PubMed ID: 1874490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bile acid metabolism in hepatic tissue of healthy subjects and in patients with liver cirrhosis].
    Erb W; Haase A; Leuschner U
    Z Gastroenterol; 1973 Apr; 11(3):203-16. PubMed ID: 4803420
    [No Abstract]   [Full Text] [Related]  

  • 15. Impaired lithocholate sulfation in the rhesus monkey: a possible mechanism for chenodeoxycholate toxicity.
    Gadacz TR; Allan RN; Mack E; Hofmann AF
    Gastroenterology; 1976 Jun; 70(6):1125-9. PubMed ID: 817960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bile acids in the liver parenchyma patients with and without gallstones].
    Brühl W; Zepke D
    Schweiz Med Wochenschr; 1973 Jun; 103(24):870-3. PubMed ID: 4712018
    [No Abstract]   [Full Text] [Related]  

  • 17. [Formation of bile acid sulfate esters in perfused rat livers following bile duct occlusion].
    Liersch M; Stiehl A
    Z Gastroenterol; 1974 Mar; 12(2):131-4. PubMed ID: 4825092
    [No Abstract]   [Full Text] [Related]  

  • 18. Biliary deoxycholate in patients with alcoholic cirrhosis.
    Mehta SJ; Struthers JE; Kaye MD; Naylor JL
    Gastroenterology; 1974 Oct; 67(4):674-9. PubMed ID: 4412192
    [No Abstract]   [Full Text] [Related]  

  • 19. A note on bile acids transformations by strains of Bifidobacterium.
    Ferrari A; Pacini N; Canzi E
    J Appl Bacteriol; 1980 Oct; 49(2):193-7. PubMed ID: 7216922
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors affecting gall-stone dissolution rate during chenic acid therapy.
    Maudgal DP; Kupfer RM; Northfield TC
    Gut; 1983 Jan; 24(1):7-10. PubMed ID: 6848433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.